Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
The aim of this study was to investigate the efficacy of insulin degludec used for basal-bolus insulin regimen after switching from twice-daily basal insulin in Japanese patients with type 1 diabetes mellitus. The subjects were 22 type 1 diabetes patients treated with basal-bolus insulin regimen wit...
Saved in:
| Main Authors: | Yuka Tosaka, Akio Kanazawa, Fuki Ikeda, Mayu Iida, Junko Sato, Kazuhisa Matsumoto, Toyoyoshi Uchida, Yoshifumi Tamura, Takeshi Ogihara, Tomoya Mita, Tomoaki Shimizu, Hiromasa Goto, Chie Ohmura, Yoshio Fujitani, Hirotaka Watada |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/176261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intelligent Dual Basal–Bolus Calculator for Multiple Daily Insulin Injections via Offline Reinforcement Learning
by: Junyoung Yoo, et al.
Published: (2024-01-01) -
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01) -
Clinical Outcomes of Switching U-100 Intermediate or Basal Insulin to U-200 Insulin Degludec or U-300 Insulin Glargine
by: Natalie Rosario, et al.
Published: (2025-03-01) -
Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
by: Marina Vladimirovna Shestakova, et al.
Published: (2015-12-01) -
The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
by: M. V. Shestakova, et al.
Published: (2021-07-01)